[{"address1": "One Central Plaza", "address2": "5th Floor 36 Dame Street", "city": "Dublin 2", "zip": "D02 K7K5", "country": "Ireland", "phone": "353 0 166 99020", "website": "https://www.amarincorp.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.", "fullTimeEmployees": 275, "companyOfficers": [{"maxAge": 1, "name": "Mr. Aaron D. Berg", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1247732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter L. Fishman", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 472899, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven B. Ketchum Ph.D.", "age": 59, "title": "Executive VP, President of Research & Development and Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1170174, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan N. Provoost", "age": 54, "title": "Executive VP, Chief Legal & Compliance Officer and Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 701819, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jordan  Zwick", "age": 37, "title": "Senior VP of Corporate Business Development & Investor Relations", "yearBorn": 1987, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Laurent  Abuaf", "title": "President of Europe & Senior VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nabil  Abadir", "title": "Chief Medical Officer of Global Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Keenan Ph.D.", "title": "Executive VP of Technical Operations & President of Europe", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investor.amarincorp.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.79, "open": 15.8, "dayLow": 15.77, "dayHigh": 16.14, "regularMarketPreviousClose": 15.79, "regularMarketOpen": 15.8, "regularMarketDayLow": 15.77, "regularMarketDayHigh": 16.14, "payoutRatio": 0.0, "beta": 0.718, "forwardPE": -75.333336, "volume": 48280, "regularMarketVolume": 48280, "averageVolume": 118390, "averageVolume10days": 104700, "averageDailyVolume10Day": 104700, "bid": 15.7, "ask": 16.07, "bidSize": 1, "askSize": 1, "marketCap": 327584736, "fiftyTwoWeekLow": 7.0, "fiftyTwoWeekHigh": 17.49, "priceToSalesTrailing12Months": 1.5299691, "fiftyDayAverage": 13.396, "twoHundredDayAverage": 11.2196, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6445907456, "profitMargins": -0.41066003, "floatShares": 375124088, "sharesOutstanding": 20707000, "sharesShort": 430048, "sharesShortPriorMonth": 558376, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0208, "heldPercentInsiders": 0.01698, "heldPercentInstitutions": 0.18205999, "shortRatio": 4.66, "shortPercentOfFloat": 0.030299999, "impliedSharesOutstanding": 414185984, "bookValue": 22.863, "priceToBook": 0.69194764, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -87927000, "trailingEps": -4.4, "forwardEps": -0.21, "lastSplitFactor": "1:20", "lastSplitDate": 1744329600, "enterpriseToRevenue": 30.105, "enterpriseToEbitda": -116.113, "52WeekChange": 0.0012657642, "SandP52WeekChange": 0.13161862, "quoteType": "EQUITY", "currentPrice": 15.82, "targetHighPrice": 12.0, "targetLowPrice": 9.0, "targetMeanPrice": 10.5, "targetMedianPrice": 10.5, "recommendationMean": 4.0, "recommendationKey": "underperform", "numberOfAnalystOpinions": 2, "totalCash": 281787008, "totalCashPerShare": 0.68, "ebitda": -55514000, "totalDebt": 10340000, "quickRatio": 2.392, "currentRatio": 3.529, "totalRevenue": 214112000, "debtToEquity": 2.183, "revenuePerShare": 10.4, "returnOnAssets": -0.050580002, "returnOnEquity": -0.17247, "grossProfits": 111082000, "freeCashflow": 9062250, "operatingCashflow": -30878000, "revenueGrowth": -0.257, "grossMargins": 0.5188, "ebitdaMargins": -0.25928, "operatingMargins": -0.39876997, "financialCurrency": "USD", "symbol": "AMRN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -4.4, "epsForward": -0.21, "epsCurrentYear": -2.01, "priceEpsCurrentYear": -7.8706465, "fiftyDayAverageChange": 2.4239998, "fiftyDayAverageChangePercent": 0.18094952, "twoHundredDayAverageChange": 4.6004, "twoHundredDayAverageChangePercent": 0.41003245, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "4.0 - Underperform", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Amarin Corporation plc", "longName": "Amarin Corporation plc", "corporateActions": [], "postMarketTime": 1752879368, "regularMarketTime": 1752868801, "exchange": "NCM", "messageBoardId": "finmb_407863", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 733674600000, "postMarketChangePercent": 0.0, "postMarketPrice": 15.82, "postMarketChange": 0.0, "regularMarketChange": 0.0299997, "regularMarketDayRange": "15.77 - 16.14", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 118390, "fiftyTwoWeekLowChange": 8.82, "fiftyTwoWeekLowChangePercent": 1.26, "fiftyTwoWeekRange": "7.0 - 17.49", "fiftyTwoWeekHighChange": -1.6700001, "fiftyTwoWeekHighChangePercent": -0.09548314, "fiftyTwoWeekChangePercent": 0.12657642, "earningsTimestamp": 1746615600, "earningsTimestampStart": 1753792200, "earningsTimestampEnd": 1754310600, "earningsCallTimestampStart": 1746619200, "earningsCallTimestampEnd": 1746619200, "isEarningsDateEstimate": true, "regularMarketChangePercent": 0.189992, "regularMarketPrice": 15.82, "displayName": "Amarin", "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]